Denik Pharma INSUGRO

​Denik Pharm offers INSUGRO, a synthetic peptide comprising IGF-1 LR3 (Insulin-Like Growth Factor 1 Long Arg3), designed to promote muscle growth, enhance recovery, and aid fat loss.

Contents and Administration:

• Vial: Each vial contains 125 mcg of IGF-1 LR3.
• Ampule: Includes 2 ml of sterile water for injection.
• Administration: Recommended as an intramuscular injection.
• Storage: Before reconstitution, store at room temperature, away from heat and direct sunlight. After reconstitution, refrigerate between 2-8°C.

Dosage Guidelines:

• Initial: 0.5 mcg/kg/day, with gradual increases possible.
• Maximum: Up to 5 mcg/kg/day.
• Duration: Do not exceed 45 days of continuous administration.

Contraindications:

INSUGRO is not suitable for individuals with:

• Acute critical illnesses (e.g., heart surgery, multiple trauma, respiratory failure).
• Active neoplasms or certain eye conditions like proliferative diabetic retinopathy.
• Lactation or closed epiphyses.
• Intracranial lesions or severe obesity with respiratory impairment.

Special Precautions:

Users should monitor:

• Thyroid function and watch for signs of intracranial hypertension.
• Diabetes, as dose adjustments in insulin may be necessary.
• Exercise caution during pregnancy.
• Discontinue if tumor growth is detected.
• Regular monitoring is advised for patients with scoliosis due to potential progression risks.

Potential Side Effects:

Users may experience:

• Tiredness, lethargy, head rush, or euphoria.
• Itching or localized reactions at the injection site.

Drug Interactions:

High doses of corticosteroids may diminish the growth-promoting effects of IGF-1 LR3.

Denik Pharm is committed to producing high-quality formulations, as evidenced by their WHO and GMP certifications.